Chemoinformaics analysis of JACEIDIN-7-RHAMNOSIDE
| Molecular Weight | 506.46 | nRot | 6 |
| Heavy Atom Molecular Weight | 480.252 | nRig | 24 |
| Exact Molecular Weight | 506.142 | nRing | 4 |
| Solubility: LogS | -4.095 | nHRing | 2 |
| Solubility: LogP | 1.553 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 62 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 36 | No. of Aromatic Carbocycles | 2 |
| nHetero | 12 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 24 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 12 | No. of Arom Bond | 17 |
| nHA | 12 | APOL | 67.0406 |
| nHD | 5 | BPOL | 37.3674 |
| QED | 0.322 |
| Synth | 4.049 |
| Natural Product Likeliness | 1.908 |
| NR-PPAR-gamma | 0.957 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.406 |
| Pgp-sub | 0.937 |
| HIA | 0.238 |
| CACO-2 | -5.812 |
| MDCK | 0.0000254 |
| BBB | 0.047 |
| PPB | 0.741152 |
| VDSS | 0.863 |
| FU | 0.27897 |
| CYP1A2-inh | 0.033 |
| CYP1A2-sub | 0.958 |
| CYP2c19-inh | 0.016 |
| CYP2c19-sub | 0.494 |
| CYP2c9-inh | 0.015 |
| CYP2c9-sub | 0.6 |
| CYP2d6-inh | 0.033 |
| CYP2d6-sub | 0.266 |
| CYP3a4-inh | 0.083 |
| CYP3a4-sub | 0.076 |
| CL | 5.015 |
| T12 | 0.642 |
| hERG | 0.031 |
| Ames | 0.656 |
| ROA | 0.105 |
| SkinSen | 0.029 |
| Carcinogencity | 0.12 |
| EI | 0.015 |
| Respiratory | 0.039 |
| NR-Aromatase | 0.851 |
| Antiviral | Yes |
| Prediction | 0.887427 |